Bacterial infections associated with COVID-19 in patients of the Intensive Care Unit
Keywords:
coronavirus, COVID-19, intensive care unit, antimicrobial resistance, SARS-CoV-2, bacterial infection, deathAbstract
Introduction: The first reports from China suggested that coinfection with other pathogens in COVID-19 was abnormal, the latest evidence has shown that other infections may appear, especially in severe patients.
Objective: To describe the bacterial infections associated with COVID-19, in patients in an intensive care unit.
Methods: A descriptive study was carried out in the period from March 24 to May 24, 2020, in the intensive care unit of the Military Hospital "Comandante Manuel Piti Fajardo". The study population consisted of 13 patients from 49 to 91 years, those who remained hospitalized in that room, with a confirmed diagnosis, by the real-time reverse transcriptase-polymerase chain reaction test for SARS-CoV-2. The study variables were: age, sex, clothing, personal pathological history, status at discharge, isolated microorganisms and antimicrobial susceptibility.
Results: 61.5% of the patients were female, the mean age was 78.8 years, 61.5% died, and among these, 44.4% had coinfection. 66.7% and 55.6% of those with high blood pressure and ischemic heart disease, respectively, developed a coinfection. Escherichia coli was the most frequently isolated microorganism.
Conclusions: Females predominated in the series studied, mortality was high, a high percentage of bacterial preparation and comorbidities was evident. More than half of the patients died. Gram-negative bacteria were the microorganisms that were most isolated. Antimicrobial resistance levels were high.
Downloads
References
2. Madrigal Rojas JP, Quesada Loría M, García Sánchez M, Solano Chinchilla A. SARS CoV-2, manifestaciones clínicas y consideraciones en el abordaje diagnóstico de COVID-19. Revista Médica de Costa Rica. 2020 [acceso: 17/05/2020];85(629):[aprox. 3 p.]. Disponible en: http://www.revistamedicacr.com/index.php/rmcr/article/viewFile/287/264
3. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 [acceso: 07/05/2020];395(10223): 507-513. Disponible en: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2820%2930211-7/fulltext#seccestitle150
4. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 [acceso: 11/05/2020];579:270-3. Disponible en: https://doi.org/10.1038/s41586-020-2012-7
5. Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens. JAMA. 2020[acceso: 11/05/2020];323(20):2085-6. Disponible en: http://scholar.google.com/scholar_url?url=https://jamanetwork.com/journals/jama/articlepdf/2764787/jama_kim_2020_ld_200032.pdf&hl=es&sa=T&oi=ucasa&ct=ufr&ei=Y9jCXqTAHPiLy9YP8KehmAo&scisig=AAGBfm2hiKsZ6FMpE4himcrxSVDe56yXmA&nossl=1
6. Monté Cerero L, Martínez Casanueva R. Microorganismos aislados en pacientes ingresados. Hospital "Salvador Allende", La Habana. Febrero a junio de 2015. Revista Habanera de Ciencias Médicas. 2017[acceso: 07/05/2020];16(4):[aprox. 11 p.]. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/1326
7. Díaz Medina LM, Medina García M, Duque González AC, Miguélez Nodarse R. Susceptibilidad antimicrobiana en muestras clínicas de pacientes con infecciones asociadas a la atención de salud. Revista Habanera de Ciencias Médicas. 2017[acceso: 07/05/2020];16(3):[aprox. 14 p.]. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/1650
8. González Castro A, Escudero Acha P, Peñasco Y, Leizaola A, Martínez de Pinillos Sánchez V, García de Lorenzo A. Cuidados intensivos durante la epidemia de coronavirus 2019. Medicina Intensiva. 2020. [acceso: 27/05/2020]. Disponible en: https://www.sciencedirect.com/science/article/pii/S0210569120300899
9. Acosta G, Escobar G, Bernaola G, Alfaro J, Taype W, Marcos C, et al. Caracterización de pacientes con COVID-19 grave atendidos en un hospital de referencia nacional del Perú. Rev Peru Med Exp Salud Pública. 2020[acceso: 29/05/2020];37(2):253-8. Disponible en: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/5437/3535
10. Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020[acceso: 26/05/2020]; 0954162(478):1-4. Disponible en: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa530/5828058
11. Fernández Rodríguez A, Casas I, Culebras E, Morilla E, Cohen MC, Alberola J. "COVID-19 y estudios microbiológicos post mortem". Revista Española de Medicina Legal. 2020[acceso: 26/05/2020];46(3):127-38. Disponible en: https://www.sciencedirect.com/science/article/pii/S0377473220300304/pdf?md5=ec25ee2a89a69b3bd95fae7f52ebbcbe&pid=1-s2.0-S0377473220300304-main.pdf
12. Kirchhelle C, Roberts A, Singer AC. Antibiotic Resistance Could Lead to More COVID-19 Deaths. Scientific American. 2020[acceso: 30/05/2020];2(2):[aprox. 8 pant.] Disponible en:https://blogs.scientificamerican.com/observations/antibiotic-resistance-could-lead-to-more-covid-19-deaths/
13. Kluge S, Janssens U, Welte T, Weber-Carstens S, Marx G, Karagiannidis C. German recommendations for critically ill patients with COVID 19. Med Klin Intensivmed Notfmed. 2020[acceso: 26/05/2020];1-4. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155395/
Published
How to Cite
Issue
Section
License
Authors who have publications with this Journal accept the following terms:
- The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
- The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
- Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.